Molecular Templates, Inc.
MTEMDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001183765
Molecular Templates, Inc. was delisted in 2025; its insiders filed their last Form 4 on Nov 18, 2024; no institution reported holding it in 13F filings for Q1 2025; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Molecular Templates, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Molecular Templates, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| BB Biotech AG | 10% Owner | 0 | Nov 18, 2024 | 0 |
| Biotech Target N V | 10% Owner | 0 | Nov 18, 2024 | 0 |
| Hoffmann Dave | Director | – | Sep 30, 2024 | 0 |
| Selick Harold E | Director | – | Sep 30, 2024 | 0 |
| Lalande Kevin M. | Director, 10% Owner | 175,000Indirect | Sep 30, 2024 | 0 |
| Sanders Corazon (Corsee) D. | Director | – | Sep 30, 2024 | 0 |
| Gruia Gabriela | Director | – | Sep 30, 2024 | 0 |
| Poma Eric E | See remarks | 277,615 | Jan 25, 2024 | 0 |
| Voi Maurizio | Chief Medical Officer | – | Jan 25, 2024 | 0 |
| Kim Jason S. | Chief Financial Officer | 95,493 | Jan 25, 2024 | 0 |
| Lanfear Jonathan | Director | – | Oct 31, 2023 | 0 |
| Waltzman Roger J. | See remarks | – | Feb 17, 2023 | 0 |
| French Douglas D | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| Sante Health Ventures I LP | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| SHV Management Services, LLC | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| SHV Management Services, LP | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| Cunningham Joe H | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| Sante Health Ventures I Annex Fund, LP | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| SHV Annex Services, LP | 10% Owner | 222,000Indirect | Jun 21, 2022 | 0 |
| McLennan Sean | See remarks | 30,000 | Jun 21, 2022 | 0 |
| Hirsch David | Director | – | Jun 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 (view filing)9:12 PM ET | Nov 14 | 4 days | BB Biotech AG and 1 other10% Owner | SSale | −1.28M | $0.6609 | −$845.8K | −100.0%0 after | |
| Nov 18, 2024 (view filing)9:12 PM ET | Apr 2 | 230 daysLate | BB Biotech AG and 1 other10% Owner | PPurchase | +904.0K | $0.4563 | +$412.5K | –769.3K after | Derivative2 lotsDuplicate filing |
| Apr 4, 2024 (view filing)8:13 PM ET | Apr 2 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +250.0K | $2.35 | +$587.5K | +24.3%1.28M after | |
| Apr 4, 2024 (view filing)8:13 PM ET | Apr 2 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +904.0K | $0.4563 | +$412.5K | –769.3K after | Derivative2 lots |
| Jul 19, 2023 (view filing)3:14 PM ET | Jul 17 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +4.26M | $0.47 | +$2.00M | +38.0%15.4M after | |
| Jun 21, 2022 (view filing)5:09 PM ET | Jun 13-15 | 8 daysLate | French Douglas D and 6 others10% Owner | PPurchase | +222.0K | $0.8936 | +$198.4K | New position222.0K after | 3 lotsDuplicate filing |
| Jun 21, 2022 (view filing) | Jun 13-15 | 8 daysLate | Lalande Kevin M.Director, 10% Owner | PPurchase | +222.0K | $0.8936 | +$198.4K | New position222.0K after | 3 lots |
| Jun 21, 2022 (view filing) | Jun 16 | 5 days | McLennan SeanSee remarks | PPurchase | +30.0K | $0.82 | +$24.6K | New position30.0K after | |
| May 18, 2022 (view filing)12:21 PM ET | May 16 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +200.0K | $1.18 | +$236.2K | +1.8%11.2M after | |
| Jan 10, 2022 (view filing)11:49 AM ET | Jan 6 | 4 days | BB Biotech AG and 1 other10% Owner | PPurchase | +200.0K | $4.04 | +$807.2K | +1.9%11.0M after | |
| Sep 23, 2021 (view filing)11:50 AM ET | Sep 21 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +750.0K | $6.00 | +$4.50M | +7.5%10.8M after | |
| Sep 20, 2021 (view filing)12:17 PM ET | Sep 16 | 4 days | BB Biotech AG and 1 other10% Owner | PPurchase | +100.0K | $6.13 | +$613.0K | +1.0%10.0M after | |
| Jul 28, 2021 (view filing)12:23 PM ET | Jul 26-27 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +155.0K | $7.04 | +$1.09M | +1.6%9.94M after | 2 lots |
| Jul 21, 2021 (view filing)2:02 PM ET | Jul 19-20 | 2 days | BB Biotech AG and 1 other10% Owner | PPurchase | +244.4K | $7.05 | +$1.72M | +2.6%9.79M after | 2 lots |